Linking Medicinal/Nutraceutical Products Research with Commercialization

References

• Anonymous (1999): Evaluation of ellagic acid content of Ohio berries—Final Report, Ohio State University Extension Information. Available at http://fruit.osu.edu/eacid_final.html, [CSA]
   Google Scholar
• Anonymous (2002): Update on spindle poisons—Part I. Taxanes, generic paclitaxel, and novel formulations and analogs. Future Oncology 6: 1422–1455. [CSA]
   Google Scholar
• Baloglu E, Kingston DGI (1999): The taxane diterpenoids. J Nat Prod 62: 1448–1472. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Croom EM (1995): Taxus. for taxol and taxoids. In: Suffness M, ed., Taxol®: Science and Applications. Boca Raton, FL, CRC Press, pp. 37–70.
   Google Scholar
• Cunningham AB, Mbenkum FT (1993): Sustainability of harvesting Prunus africana. bark in Cameroon: A medicinal plant in international trade. People and Plants Working Paper 2. Paris, UNESCO, p. 28.
   Google Scholar
• DasGupta TK, Pezzuto JM (1997): Method and composition for selectively inhibiting melanoma using betulinic acid. US Patent No. 5,658,947.
   Google Scholar
• DiMasi JA, Hansen RW, Grabowski HG (2003): The price of innovation: New estimates of drug development costs. J Health Econ 22: 151–185. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Farnsworth, NN, Soejarto, DD (1991): Global importance of medicinal plants. In: Akerle O, Heywood OV, Synge H, eds., Conservation of Medicinal Plants. Cambridge, UK, Cambridge University Press, pp. 25–51.
   Google Scholar
• Garber K (2002): Battle over generic taxol concludes, but controversy continues. J Natl Cancer Inst 94: 324–326. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Goodman, J, Walsh V (2001): The Story of Taxol: Nature and Politics in Pursuit of an Anti-Cancer Drug. Cambridge, UK, Cambridge University Press, pp. 282.
   Google Scholar
• Govindachari TR, Viswanathan N (1972): Alkaloids of Mappia foetida.. Phytochemistry 11: 3529–3531. [CSA], [CROSSREF]
   Google Scholar
• Iwu, MM (2002a): Ethnobotanical approach to pharmaceutical drug discovery: Strengths and limitations. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 309–320.
   Google Scholar
• Iwu, MM (2002b): Introduction: Therapeutic agents from ethnomedicine. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 1–22.
   Google Scholar
• Iwu, MM, Diop AD, Miserole L, Okuni CO (2002): Garcinia kola.: A new look at an old adaptogenic agent. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 191–199.
   Google Scholar
• Leakey RRB, Izac A-MN (1996): Linkages between domestication and commercialization of non-timber forest products: Implications for agroforestry. In: Leakey RRB, Temu AB, Melnyk M, Vantomme P, eds., Domestication and Commercialization of Non-timber Forest Products: Implications in Agroforestry Systems. Rome, FAO, pp. 1–7.
   Google Scholar
• Leakey RRB, Newton AC (1994): Domestication of ‘Cinderella’ species as the start of a woody-plant revolution. In: Leakey RRB, Newton AC, eds., Tropical Trees: Potential for Domestication and the Rebuilding of Forest Resources. London, HMSO, pp. 3–5.
   Google Scholar
• Manual of Patent Examining Procedure (2001). Chapter 2100, Section 2105, “Patentable Subject Matter—Living Subject Matter,” 8th ed. (rev. May 2004). Washington, DC, U.S. Department of Commerce. USPTO. Available at http://www.uspto.gov/web/offices/pac/mpep/mpep.htm
   Google Scholar
• Marles RJ, Clavelle C, Monteleone L, Tays N, Burns D (2000): Aboriginal Plant Use in Canada's Northwest Boreal Forest, Vancouver, BC, UBC Press, pp. 253–256.
   Google Scholar
• McChesney JD (2000): Commercialization of plant-derived natural products as pharmaceuticals: A view from the trenches. In: Cutler SJ, Cutler HG, eds., Biologically Active Natural Products: Pharmaceuticals. Boca Raton, FL, CRC Press, pp. 253–264.
   Google Scholar
• Moerman DE (1998): Native American Ethnobotany. Portland, OR, Timber Press, pp. 11–28.
   Google Scholar
• Moraes RM, Burandt C Jr., Ganzera M, Li X, Khan I, Canel C (2000): The American mayapple revisited—Podophyllum peltatum.—still a potential cash crop? Econ Bot 54: 471–476. [CSA]
   Web of Science ®Google Scholar
• Nikolakakis A, Caron G, Cherestes A, Sauriol F, Mamer O, Zamir LO (2000). Taxus canadensis. abundant taxane: Conversion to paclitaxel and rearrangements. Bioorganic Med Chem 8: 1269–1280. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shaw A (1987): Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances. Section II.D.6.c (1). Washington, DC, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration. Available at http://www.fda.gov/cder/guidance/drugsub.pdf
   Google Scholar
• Schippmann U (2001): Medicinal Plants Significant Trade Study. CITES Document PC9.9.1.3 (rev.). Bonn, Bundesamt für Naturschutz (BIN), pp. 71–74. [CSA]
   Google Scholar
• Schmidt RJ (2002): The Botanical Dermatology Database (BoDD): Cupressaceae (Cypress family). Available at http://bodd.cf.ac.uk/BotDermFolder/BotDermC/CUPR.html, [CSA]
   Google Scholar
• Small E, Catling PM (1999): Canadian Medicinal Crops. Ottawa, NRC Research Press, pp. 240.
   Google Scholar
• Walker K, Croteau R (2001). Taxol biosynthetic genes. Phytochemistry 58: 1–7. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wall ME, Wani MC, Nicholas AW, Manikumar G (1990): Synthesis of camptothecin and analogs thereof. U.S. Patent No. 4,894,456. [CSA]
   Google Scholar
• Williams JE (2001): Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Uña de Gato and Sangre de Grado. Altern Med Rev 6: 567–579. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar